サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788207

非侵襲的冠動脈イメージングの世界市場

Non-invasive Coronary Imaging

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.69円
非侵襲的冠動脈イメージングの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

非侵襲的冠動脈イメージングの世界市場は2030年までに5億3,060万米ドルに達する見込み

2024年に3億9,230万米ドルと推定される非侵襲的冠動脈イメージングの世界市場は、2030年には5億3,060万米ドルに達し、分析期間2024-2030年のCAGRは5.2%で成長すると予測されます。本レポートで分析しているセグメントの1つである心エコー検査は、CAGR 3.5％を記録し、分析期間終了時には2億480万米ドルに達すると予測されています。心臓コンピュータ断層撮影の成長率は、分析期間中CAGR 6.6%と推定されます。

米国市場は1億690万米ドルと推定、中国はCAGR7.9％で成長予測

米国の非侵襲的冠動脈イメージング市場は、2024年に1億690万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億400万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6％と5.0％と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の非侵襲的冠動脈イメージング市場- 主要動向と促進要因のまとめ

非侵襲的冠動脈イメージングは心血管診断のゲームをどう変えるか？

非侵襲的冠動脈イメージングは、カテーテルを用いた手技を必要とせず、より安全で迅速、かつ高精度の冠動脈疾患（CAD）評価法を臨床医に提供し、心血管診断の展望に革命をもたらしています。従来の冠動脈造影検査は、効果的ではあるが、その侵襲的な性質により、潜在的な血管損傷、造影剤に対するアレルギー反応、検査後の回復時間など、大きな患者リスクを伴う。これとは対照的に，冠動脈コンピュータ断層撮影法（CCTA），心臓磁気共鳴画像法（CMR），陽電子放射断層撮影法（PET）などの非侵襲的技術は，冠動脈血管の高解像度の可視化を，手技リスクを軽減しながら可能にしています。これらの技術は、プラークの蓄積を検出し、狭窄を評価し、全体的な心臓機能を評価する上で極めて重要なものとなっています。患者にとっては、検査時間の短縮、不快感の軽減、入院期間の短縮といった大きなメリットがあり、一方、医師にとっては、詳細な解剖学的・機能的データにアクセスすることで、より多くの情報に基づいた治療方針の決定が可能となります。さらに、非侵襲的画像診断ツールは、症状が現れるかなり前に潜在性アテローム性動脈硬化症を検出することができるため、予防的心臓病学において不可欠なものとなっています。CTから得られる分画血流予備能（FFR-CT）のような方法による機能的評価の統合もまた、解剖学的画像と生理学的洞察との間のギャップを埋め、虚血を引き起こす病変をより正確に同定することを可能にしています。心血管系疾患が依然として世界の死亡原因の第1位であることから、早期発見と疾患管理における非侵襲的画像診断の役割は、今後ますます大きくなると予想されます。

診断の精度と効率を高めるためにテクノロジーが果たす役割とは？

画像診断技術の進歩は、非侵襲的冠動脈イメージングソリューションの信頼性と採用率を高める上で中心的な役割を担っています。CTスキャナーの進化-撮影速度の高速化、被曝線量の低減、空間分解能の向上-により、冠動脈CTアンギオグラフィは冠動脈疾患が疑われる患者を評価するための最前線のツールとなりました。同時に、心臓MRIは患者に電離放射線を照射することなく、心筋の灌流、バイアビリティ、線維化を評価するために広く使用されるようになってきています。人工知能と機械学習が画像診断プラットフォームに統合されたことで、診断精度がさらに向上し、大規模なデータ解析に基づく狭窄の自動検出、プラークの特徴づけ、リスク層別化が可能になりました。また、これらの技術はワークフローを合理化し、放射線科医や心臓専門医がより速く、より一貫性をもってスキャンを解釈することを可能にします。デュアルエナジーCTとフォトンカウンティングCTは次世代の画像技術革新であり、組織コントラストを強化し、これまで冠動脈の可視化を妨げていたアーチファクトを減少させる。さらに、ストレスCMRやPETスキャンなどの機能的画像診断技術は、血行再建術の必要性を判断するのに重要な心筋血流や灌流障害について、非常に正確な洞察を提供するようになりました。電子カルテ（EHR）やクラウドベースの共有システムとの相互運用性により、シームレスなデータ統合が可能になり、施設間でのセカンドオピニオン相談も可能になりました。このような技術的飛躍は、単に精度を向上させるだけでなく、より迅速で、患者にやさしく、高度に個別化された診断経路を再構築しています。

臨床慣行の変化と患者の嗜好が採用を後押ししている？

非侵襲的冠動脈イメージングモダリティに対する需要の増加には、患者の期待の進化とともに、臨床行為の変化が極めて重要な役割を果たしています。循環器専門医や一般開業医は、安定した胸痛やリスク評価のための第一選択診断として非侵襲的画像診断を薦める傾向にあり、特にその臨床的有効性を支持するエビデンスが増えてきています。米国心臓病学会（American College of Cardiology）や欧州心臓病学会（European Society of Cardiology）のような著名な団体のガイドラインでは、不必要な侵襲的手技やそれに伴う合併症を減らすことができることが証明されているため、非侵襲的手技を支持する傾向が強まっています。患者の立場からは、利便性、不安の軽減、回復の早さへの要望から、非侵襲的な外来ベースの診断を好む傾向がこれまで以上に強くなっています。これは、侵襲的な検査がより高いリスクをもたらす高齢者や複数の合併症を持つ患者において特に関連性が高いです。また、非侵襲的な選択肢は、遠隔医療や遠隔ヘルスケアモデルにおいてより拡張性があり、診断サービスを地方や十分なサービスを受けていない地域の患者にも拡大することができます。さらに、糖尿病、肥満、高血圧などの生活習慣に関連した危険因子の増加により、特に無症状の高リスク群では、より早期かつ頻繁な心血管スクリーニングが必要とされています。病院や画像診断センターは、マルチモダリティ・イメージング・スイートへの投資や、外来診断に対応するための循環器科サービスラインの拡大によって、こうしたシフトに対応しています。これらの動向はすべて、医療提供者の戦略と患者の考え方が大きく変化していることを示しており、世界中の医療システムで非侵襲的冠動脈イメージングが長期的に採用されることを後押ししています。

非侵襲的冠動脈イメージング市場の急成長の原動力は？

非侵襲的冠動脈イメージング市場の成長は、技術革新、クリニカルパスの進化、ヘルスケア提供システムのシフトなど、いくつかの要因によって牽引されています。最も大きな原動力の1つは、侵襲的な処置特有のリスクを伴わずに、冠動脈の解剖学的構造と機能を詳細かつリアルタイムに可視化できるイメージング・プラットフォームの進歩です。スキャナーの速度、画像の解像度、後処理ソフトウェアの継続的な改善により、これらのモダリティの臨床的有用性は大幅に拡大した。エンドユーザー側では、ヘルスケアプロバイダーは、患者のトリアージを効率的に行い、不必要な心臓カテーテル検査を減らし、全体的なケアの質を向上させるために、非侵襲的画像診断への依存度を高めています。このシフトは、特にCCTAや心臓MRIといった非侵襲的手技の診断的・予後的価値を認める臨床ガイドラインの更新によって支えられています。消費者行動も市場力学に影響を及ぼしており、より安全な診断オプションを積極的に求め、予防検診プログラムに参加する患者が増加しています。さらに、AI対応の画像診断ツールの出現により、生産性が向上し、診断のばらつきが減少し、高度な解釈が一般開業医や非専門医にとってより利用しやすくなっています。病院ネットワークや画像診断センターも、リソースの利用を最適化し、診断のタイムラインを短縮し、患者のスループットを改善するために、これらの技術を取り入れています。多くの国の診療報酬体系は、このようなシフトに合わせて徐々に変化しており、非侵襲的画像診断が医療提供者にとって経済的に実行可能なものとなりつつあります。最後に、人口の高齢化、座りっぱなしのライフスタイル、食生活の乱れなどを背景に、先進国でも開発途上国でも心血管疾患の罹患率が上昇しているため、正確な早期診断ツールに対する需要が堅調かつ継続的に高まっています。これらの要因が相まって、非侵襲的冠動脈イメージング市場の世界の急拡大に拍車をかけています。

セグメント

モダリティ（心エコー、心臓コンピュータ断層撮影、心臓磁気共鳴画像、放射性核種心臓画像）;エンドユーザー（病院エンドユーザー、画像診断センターエンドユーザー、研究機関エンドユーザー）

調査対象企業の例

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32371

Global Non-invasive Coronary Imaging Market to Reach US$530.6 Million by 2030

The global market for Non-invasive Coronary Imaging estimated at US$392.3 Million in the year 2024, is expected to reach US$530.6 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Echocardiography, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Cardiac Computed Tomography segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.9 Million While China is Forecast to Grow at 7.9% CAGR

The Non-invasive Coronary Imaging market in the U.S. is estimated at US$106.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$104.0 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Non-Invasive Coronary Imaging Market - Key Trends & Drivers Summarized

How Is Non-Invasive Coronary Imaging Changing the Game in Cardiovascular Diagnosis?

Non-invasive coronary imaging is revolutionizing the landscape of cardiovascular diagnostics, offering clinicians safer, faster, and highly accurate methods to assess coronary artery disease (CAD) without the need for catheter-based procedures. Traditional coronary angiography, while effective, involves significant patient risk due to its invasive nature, including potential vascular injury, allergic reactions to contrast agents, and post-procedure recovery time. In contrast, non-invasive techniques such as coronary computed tomography angiography (CCTA), cardiac magnetic resonance imaging (CMR), and positron emission tomography (PET) are enabling high-resolution visualization of coronary vessels with reduced procedural risk. These technologies have become pivotal in detecting plaque buildup, assessing stenosis, and evaluating overall heart function. Patients benefit significantly from quicker turnaround times, minimal discomfort, and reduced hospital stays, while physicians gain access to detailed anatomical and functional data that supports more informed treatment decisions. Additionally, the ability of non-invasive imaging tools to detect subclinical atherosclerosis-well before symptoms appear-has made them indispensable in preventive cardiology. The integration of functional assessment through methods like fractional flow reserve derived from CT (FFR-CT) is also bridging the gap between anatomical imaging and physiological insight, allowing more accurate identification of ischemia-causing lesions. As cardiovascular disease remains the leading cause of mortality globally, the role of non-invasive imaging in early detection and disease management is only expected to grow stronger.

What Role Does Technology Play in Elevating Diagnostic Accuracy and Efficiency?

Advancements in imaging technologies are central to the growing reliability and adoption of non-invasive coronary imaging solutions. The evolution of CT scanners-marked by faster acquisition speeds, reduced radiation exposure, and improved spatial resolution-has made coronary CT angiography a frontline tool for evaluating patients with suspected coronary artery disease. Simultaneously, cardiac MRI is becoming more widely used to assess myocardial perfusion, viability, and fibrosis without exposing patients to ionizing radiation. The integration of artificial intelligence and machine learning into imaging platforms is further amplifying diagnostic accuracy, allowing for automated detection of stenosis, plaque characterization, and risk stratification based on large-scale data analysis. These technologies also streamline workflow, enabling radiologists and cardiologists to interpret scans faster and with greater consistency. Dual-energy CT and photon-counting CT are the next generation of imaging innovations, providing enhanced tissue contrast and reducing artifacts that previously hindered coronary visualization. Moreover, functional imaging techniques such as stress CMR and PET scans now offer highly precise insights into myocardial blood flow and perfusion defects, which are critical for determining the need for revascularization procedures. Interoperability with electronic health records (EHRs) and cloud-based sharing systems allows for seamless data integration and second-opinion consultations across institutions. These technological leaps are not just improving accuracy-they're reshaping the diagnostic pathway to be faster, more patient-friendly, and highly personalized.

Are Shifting Clinical Practices and Patient Preferences Driving Adoption?

Changing clinical practices, along with evolving patient expectations, are playing a pivotal role in the increased demand for non-invasive coronary imaging modalities. Cardiologists and general practitioners are now more inclined to recommend non-invasive imaging as a first-line diagnostic option for stable chest pain and risk assessment, especially with the growing body of evidence supporting its clinical efficacy. Guidelines from prominent organizations such as the American College of Cardiology and the European Society of Cardiology increasingly favor non-invasive modalities due to their proven ability to reduce unnecessary invasive procedures and associated complications. From the patient's perspective, the preference for non-invasive, outpatient-based diagnostics is stronger than ever, driven by a desire for convenience, lower anxiety levels, and quicker recovery. This is particularly relevant in older populations and those with multiple comorbidities, where invasive testing poses higher risks. Non-invasive options are also more scalable in telemedicine and remote healthcare models, allowing diagnostic services to be extended to patients in rural and underserved areas. Furthermore, the rising prevalence of lifestyle-related risk factors such as diabetes, obesity, and hypertension is prompting earlier and more frequent cardiovascular screening, especially in asymptomatic high-risk groups. Hospitals and imaging centers are responding to these shifts by investing in multi-modality imaging suites and expanding cardiology service lines to accommodate outpatient diagnostics. All these trends point toward a significant shift in both provider strategy and patient mindset, reinforcing the long-term adoption of non-invasive coronary imaging across healthcare systems worldwide.

What’s Powering the Rapid Growth of the Non-Invasive Coronary Imaging Market?

The growth in the non-invasive coronary imaging market is driven by several factors spanning technological innovation, evolving clinical pathways, and shifts in healthcare delivery systems. One of the foremost drivers is the advancement of imaging platforms capable of delivering detailed, real-time visualization of coronary anatomy and function without the inherent risks of invasive procedures. Continuous improvements in scanner speed, image resolution, and post-processing software have significantly broadened the clinical utility of these modalities. On the end-user side, healthcare providers are increasingly relying on non-invasive imaging to triage patients efficiently, reduce unnecessary cardiac catheterizations, and improve overall care quality. This shift is supported by updated clinical guidelines that recognize the diagnostic and prognostic value of non-invasive techniques, particularly CCTA and cardiac MRI. Consumer behavior is also influencing market dynamics, with a growing number of patients actively seeking safer diagnostic options and participating in preventive health screening programs. Additionally, the emergence of AI-enabled imaging tools has enhanced productivity, reduced diagnostic variability, and made advanced interpretation more accessible to general practitioners and non-specialist providers. Hospital networks and imaging centers are also embracing these technologies to optimize resource utilization, shorten diagnostic timelines, and improve patient throughput. Reimbursement structures in many countries are gradually aligning with these shifts, making non-invasive imaging financially viable for providers. Finally, rising cardiovascular disease prevalence across both developed and developing nations-driven by aging populations, sedentary lifestyles, and poor dietary habits-is creating a robust and ongoing demand for accurate, early-stage diagnostic tools. Together, these factors are fueling the rapid global expansion of the non-invasive coronary imaging market.

SCOPE OF STUDY:

The report analyzes the Non-invasive Coronary Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging, Radionuclide Cardiac Imaging); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Non-invasive Coronary Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Shift Toward Early Cardiovascular Risk Detection Throws the Spotlight on Non-Invasive Imaging Modalities
    • Increased Patient Preference for Radiation-Free and Painless Diagnostics Strengthens the Business Case for Non-Invasive Imaging
    • Surging Global Burden of Coronary Artery Disease Propels Growth Across Diagnostic Ecosystems
    • Integration of Functional Imaging and Anatomical Mapping Expands the Addressable Market Opportunity in Complex Cases
    • Widespread Adoption of AI-Enhanced Image Interpretation Drives Diagnostic Accuracy and Workflow Efficiency
    • Advancements in CT and MRI Technologies Accelerate Demand for High-Resolution Non-Invasive Cardiac Imaging
    • Rising Utilization in Preventive Health Programs Spurs Growth in Asymptomatic and At-Risk Populations
    • Emergence of Hybrid Imaging Platforms Strengthens Clinical Relevance and Adoption Across Hospital Systems
    • Growth in Outpatient Cardiology Services and Diagnostic Clinics Sustains Market Expansion
    • Remote Diagnostics and Teleradiology Integration Opens New Avenues in Underserved and Rural Markets
    • Increasing Emphasis on Patient Safety and Procedure Efficiency Spurs Transition from Invasive to Non-Invasive Modalities
    • Consumer Awareness and Digital Health Trends Generate Demand for Non-Invasive, Personalized Cardiac Assessments
    • Infrastructure Modernization and Cardiac Center Investments in Emerging Economies Fuel Market Penetration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-invasive Coronary Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Echocardiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Radionuclide Cardiac Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION